Independent due diligence

Swiss Medica: claims, evidence and regulatory questions

A neutral review framework based on provider-published information and official regulator sources. It is not an endorsement, accusation or substitute for independent medical advice.

Swiss Medica's own website describes activities and locations in several European countries. Those provider-published statements establish what the organisation markets; they do not independently prove the authorisation, evidence or legal route for any particular cell intervention. Location and operating entities can change, so verify the current treating site and legal entity.

Before proceeding, request the exact product, cell source, processing, dose, route, manufacturer and indication. Ask the relevant national authority to confirm the provider and product records and, if research is claimed, obtain the authorised protocol, sponsor, ethics approval and trial results. This profile does not rate or endorse the provider.

CheckWhat to request from Swiss MedicaIndependent verification
Operating entity and locationCurrent legal name, address and treating clinicianNational provider or professional register
Exact interventionProduct name, cell source, processing, dose and routeRegulator product record and authorised indication
Legal routeMarketing authorisation, authorised trial, or named exemptionConfirmation from the competent authority
ManufacturingManufacturer, site and authorisation scopeCurrent authority record applicable to that product
EvidenceProtocol, trial identifier and complete resultsRegistry status, peer-reviewed publication and regulator assessment
Patient protectionConsent, harms, insurance, emergency and follow-up plansIndependent clinician and ethics/regulatory documents
CostDated, itemised written quote and refund termsDo not treat price as evidence of approval or benefit
A provider's own website is evidence of what it markets, not independent proof that the intervention is authorised, safe or effective.

Common questions

Does a clinic licence mean every cell product it offers is authorised?

No. A facility, clinician, tissue establishment, manufacturer and medicinal product can be regulated under different legal routes. Ask the relevant authority to confirm the exact product, indication and route.

Does a trial or registry listing prove that a treatment works?

No. Registration improves transparency but does not establish efficacy, marketing authorisation or lawful commercial supply. Review the protocol, sponsor, regulatory authorisation, status and results separately.

How should I compare cell-therapy providers?

Compare the exact product and indication, legal route, manufacturing authorisation, peer-reviewed evidence, consent and adverse-event safeguards, follow-up plan and a dated itemised quote. Do not compare broad labels such as 'stem cells' alone.

Sources & further reading

Provider information reviewed in 2026 and may change. Verify current records directly with the relevant authority. Not medical advice.

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information